Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Sodium oxybate 500 mg/ml oral solution

Discontinued
Active Ingredient:
sodium oxybate
Company:  
Neuraxpharm UK Ltd See contact details
ATC code: 
N07XX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

How to take Sodium oxybate 500 mg/ml oral solution (sodium oxybate)

Important risk minimisation for patients: Sodium oxybate 500 mg/ml oral solution (sodium oxybate)

{pdf_link}

Sodium oxybate Patient alert card

Patient alert card

{pdf_link}

Sodium oxybate Guide for paediatric patients and their caregivers

Guide for paediatric patients and their caregivers

{pdf_link}

Sodium oxybate Important risk minimisation information for patients and caregivers: frequently asked questions

FAQs

{pdf_link}

Sodium oxybate Treatment Initiation and Follow-up Visit Form

{healthcare_pro_orange} For Healthcare Professionals

Initiation checklist and follow-up visit form

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Neuraxpharm UK Ltd
Company image
Address
Neuraxpharm UK Ltd, Suite 2, Arlington Flex, Third Floor, Building 1420, Arlington Business Park, Theale, Reading, Berkshire, RG7 4SA, UK
Telephone
0118 211 4039
E-mail
[email protected]
Adverse event reporting email
[email protected]
Medical Information e-mail
[email protected]